Skip to main content

Development of Eppin Pharma's technology with in vivo toxicology studies

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 9, 2014
Award amount: 
$75,000
Organization name: 
Eppin Pharma Inc
Principal Investigator: 
O'Rand, Michael G
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

Eppin Pharma is developing a reversible, oral, non-hormonal male contraceptive pill. This CIL will support toxicology testing of the company's lead molecule and will help position the company to seek additional funding from investors, federal grants, and foundations.

Fiscal year: 
2015